Skip to main content
NiceBooksReadsSTORIES BRING US TOGETHER
DiscoverWhat’s Being Read?UK booksellers
BooksEbooksAudiobooks
World Literature NewsBook FriendshipBook roomsBook Club
Creation StudiosPublish Your Own BookExperts
EnglishUS

Market controls currency, catalogue and payment options; it does not change your language.

Log inJoin
NiceBooksReadsSTORIES BRING US TOGETHER
Language
EnglishUS

Market controls currency, catalogue and payment options; it does not change your language.

Discover
⌕Discover›↗What’s Being Read?›↗UK booksellers›
Read & Listen
▥Books›▤Ebooks›▶Audiobooks›
Community
✦World Literature News›♡Book Friendship›◌Book rooms›▧Book Club›
Write & Publish
✦Creation Studios›↗Publish Your Own Book›◇Experts›
Log inJoin
← Back to library

Source and use notice

You are accessing this work through its Internet Archive source record. NiceBooksReads provides access to the source and a reading/listening interface.

Rights in the work and recording belong to their respective rights holders. Please review the source record’s licence, access and use conditions. This notice grants no additional use or republication rights.

Source record ↗Source terms of use ↗
Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.

English

Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.

Saul S. SillerKendal Broadie

This article is from Disease Models & Mechanisms , volume 4 . Abstract Fragile X syndrome (FXS), caused by loss of the fragile X mental retardation 1 (FMR1) product (FMRP), is the most common cause of inherited intellectual disability and autism spectrum disorders. FXS patients suffer multiple behavioral symptoms, including hyperactivity, disrupted circadian cycles, and learning and memory deficits. Recently, a study in the mouse FXS model showed that the tetracycline derivative minocycline effectively remediates the disease state via a proposed matrix metalloproteinase (MMP) inhibition mechanism. Here, we use the well-characterized Drosophila FXS model to assess the effects of minocycline treatment on multiple neural circuit morphological defects and to investigate the MMP hypothesis. We first treat Drosophila Fmr1 (dfmr1) null animals with minocycline to assay the effects on mutant synaptic architecture in three disparate locations: the neuromuscular junction (NMJ), clock neurons in the circadian activity circuit and Kenyon cells in the mushroom body learning and memory center. We find that minocycline effectively restores normal synaptic structure in all three circuits, promisin

Sign in with your free account to read, download EPUBs or listen.

Read online →EPUB ↓

Report a problem with this book

Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.

About this work

Ebook · Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase. · Siller, Saul S., Broadie, Kendal · Internet Archive

Digital editions

EPUB ↓

Find other editions →

NiceBooksReadsSTORIES BRING US TOGETHER

A creative community where stories are written, read, heard and shaped with professional publishing services.

DiscoverBooksWhat’s Being Read?World Literature News
Privacy & cookiesUser agreementDistance sales agreementCookie settings
●Secure connectionProtected with HTTPS and SSL/TLS encryption
Payment cards
VISAmastercardtroy
© 2026 NiceBooksReads · All rights reserved.